Clinical Trial

SUTURE-CLOSURE OMENTOPEXY VERSUS OMENTOPEXY ALONE IN REPAIR OF PERFORATED PEPTIC ULCER

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 13, 2024 (before its estimated May 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The present study will be conducted to assess whether there is a direct benefit associated with modified-Graham's omentopexy (MGO), above and beyond the benefit associated with Graham's omentopexy (GO) in the treatment of perforated duodenal ulcers. We attempted to answer the question whether primary closure of the perforation in MGO will affect the outcome of surgery. Complication rates will be compared for the two alternative surgical procedures.
Trial Details
NCT Number NCT06550856
Lead Sponsor Sohag University
Conditions Perforated Peptic Ulcer
Enrollment 50 participants
Start Date 2024-07-15
Primary Completion 2025-05-01 (estimated)
Study Completion 2025-05-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-13